Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Pancreatic Cancer · Renal Cell Cancer · Breast Cancer · Melanoma · Ovarian Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center) · irc@nih.gov · 866-820-4505
Study leads
James C Yang, M.D.
Principal Investigator
National Cancer Institute (NCI)